BEIJING – China is tightening regulations on the clinical use of high-risk or ethically controversial diagnostic and therapeutic technologies.
The Ministry of Health (MOH) issued a government order on Monday requiring hospitals to get approval before doing things such as artificial heart implants and homogeneous organ transplants.
The regulation goes in to effect May 1. Hospitals already using the technologies are required to report to the Ministry for verification of qualifications within six months after that date.
The MOH said its aim is to prevent abuses of those medical technologies. Previously, only some needed government approval, it said, without giving further details.
Continue reading ‘China – tightens regulations on risky medical technologies’
Maybe you can find something interesting in the following sponsored links:
Incoming search terms:
Xuetao Pei, china stem cell news, regenexx for kidney transplant patient, retinal progenitor cells for dettach retina in china, stem cell china comparison, stem cell china risk, stem cell therapy after kidney transplant china, stem cell transplant complications, stem cell transplant diagram, stem cell treatment iafter kidney transplant singapore, stem cells news china, the guardian stem cells beijing, news related to medical technology risk, new controversial medical technology, myeloma stem cell transplant, Chinas Stem-Cell Therapy for Kids Is Risky, chinese kidney stem cell transplant, govt sponsored hospitals cell transfusion treatment for diabetics 2, how to use new medical technology on bbc news, IMAGE OF TECHNOLOGY IN KIDNEY TRANSPLANT, kidney stem cell china, kidney transplant breakthrough 2011, medical technology kidney, medical technology kidney transplant, military stem cells china, china stem cell kidney transplant.
